Skip to content

Disc Medicine IRON Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$241.6M-107%-$212.18M-94.0%-$181.11M-75.0%-$145.39M-59.8%-$116.49M-44.5%
$350K+133%$281K+80.1%$201K+16.9%$125K-32.8%$150K+48.5%
$39.92M+109%$34.34M+104%$28.63M+98.7%$23.45M+107%$19.12M+123%
-$201.25M-97.9%-$180.39M-92.1%-$164.67M-95.7%-$134.23M-80.7%-$101.7M-42.1%
$82K$933K$1.36M
-$564.9M-444,702%
$0-100%$7.25M-66.7%$14.49M0.0%$21.74M+200%
$230.85M-48.3%$473.41M+117%$285.53M+44.7%$274.37M+39.1%$446.67M+151%
-$219.94M
-$201.34M-95.5%-$181.33M-92.0%-$166.03M-97.2%-$135.56M-82.3%-$102.99M-43.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Disc Medicine generate?
Disc Medicine (IRON) generated -$201.3M in operating cash flow over the trailing twelve months.
What is Disc Medicine's free cash flow?
After $82.0K of capital expenditures, Disc Medicine's free cash flow was -$201.3M over the trailing twelve months, down 95.5% year over year.
Where does Disc Medicine's cash flow data come from?
Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.